Hechos relevantes

GRIFOLS, S.A.

desde 01/07/1988 hasta 02/02/2023

• • 26/01/2018
  • 08:27
  • GRIFOLS, S.A.
  • Others on corporate transactions
  • Acquisition of 51% of the share capital in Goetech LLC (MedKeeper).
  • Número de registro: 260997
  • 
• • 05/12/2017
  • 11:49
  • GRIFOLS, S.A.
  • Loans, credit lines and guarantees
  • Grifols has obtained a new long-term loan with the European Investment Bank
  • Número de registro: 259188
  • 
• • 22/11/2017
  • 17:42
  • GRIFOLS, S.A.
  • Others on business performance and financial information
  • Grifols inaugurates a plant in Brazil
  • Número de registro: 258783
  • 
• • 17/11/2017
  • 17:31
  • GRIFOLS, S.A.
  • R&D: new licenses, patents and registered trademarks
  • Grifols has earned approvals from the U.S. Food and Drug Administration and from the European Medicines Agency
  • Número de registro: 258667
  • 
• • 16/11/2017
  • 08:25
  • GRIFOLS, S.A.
  • Information on dividends
  • Details of the interim dividend on account of 2017 profit
  • Número de registro: 258581
  • 
• • 06/11/2017
  • 08:24
  • GRIFOLS, S.A.
  • R&D: new licenses, patents and registered trademarks
  • Grifols informs that it has earned approval from the U.S. FDA for a new product: Fibrin Sealant (Human)
  • Número de registro: 258231
  • • Relacionado con 252988 del 07/06/2017 (07:39)
  • 
• • 02/11/2017
  • 08:24
  • GRIFOLS, S.A.
  • Information on P&L
  • Performance summary for the third quarter 2017
  • Número de registro: 258082
  • 
• • 02/11/2017
  • 08:22
  • GRIFOLS, S.A.
  • Interim financial information
  • La sociedad remite información sobre los resultados del tercer trimestre de 2017
  • Número de registro: 258081
  • 
• • 30/10/2017
  • 08:18
  • GRIFOLS, S.A.
  • Information on dividends
  • Approval of interim dividend on account of 2017 profit
  • Número de registro: 257978
  • 
• • 22/09/2017
  • 08:26
  • GRIFOLS, S.A.
  • R&D: new licenses, patents and registered trademarks
  • Grifols has earned approval from the U.S. Food and Drug Administration for a liquid formulation of its alpha-1 antitrypsin as a replacement therapy to treat alpha-1 antitrypsin deficiency, a rare genetic disorder.
  • Número de registro: 256616
  •